Scarica l'app Stockscreener
29.28
1.60%
0.46
Dopo l'orario di chiusura:
29.00
-0.28
-0.96%
Precedente Chiudi:
$28.82
Aprire:
$28.75
Volume 24 ore:
497.98K
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.51B
Reddito:
$412.82M
Utile/perdita netta:
$-8.19M
Rapporto P/E:
-190.01
EPS:
-0.1541
Flusso di cassa netto:
$64.17M
1 W Prestazione:
+16.89%
1M Prestazione:
+28.31%
6M Prestazione:
+52.50%
1 anno Prestazione:
+52.26%
Intervallo 1D:
$28.75
$29.58
Intervallo di 1 settimana:
$24.50
$29.58
Portata 52W:
$10.96
$29.58
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
29.28 | 1.49B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
506.42 | 190.65B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
192.78 | 138.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
535.93 | 43.50B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
272.31 | 37.51B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
132.83 | 38.41B | 7.23B | 1.41B | 1.09B | 4.979 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
Enterprise value to EBIT forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
Caredx Inc stock hits 52-week high at $29.08 - Investing.com
1K9 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of CareDx, Inc. – BOATS:CDNA - TradingView
Price to earnings forward of CareDx, Inc. – BOATS:CDNA - TradingView
CDNA Forecast — Price Target — Prediction for 2027 - TradingView
CareDx, Inc. Actuals & Estimates (NASDAQ:CDNA) - TradingView
CareDx Inc (CDNA) Institutional Confidence - TradingKey
Caredx Inc stock hits 52-week high at 26.7 USD By Investing.com - Investing.com Australia
Caredx Inc stock hits 52-week high at 26.7 USD - Investing.com
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CareDx's CEO Sells 17K Shares - Yahoo Finance
CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz - Sahm
Responsive Playbooks and the CDNA Inflection - Stock Traders Daily
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests - ChartMill
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Yahoo Finance
CareDx presents transplant monitoring data at medical congress - Investing.com UK
CareDx Inc (CDNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Showcases Innovations at American Transplant Congr - GuruFocus
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
CareDx Inc (CDNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CareDx presents transplant monitoring data at medical congress By Investing.com - Investing.com Nigeria
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Business Wire
How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story - Sahm
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan - Stock Titan
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - BioSpace
Insider Sell: Hannah Valantine Sells 12,103 Shares of CareDx Inc (CDNA) - GuruFocus
CareDx director Hannah Valantine sells $279,728 in stock By Investing.com - Investing.com India
CareDx director Hannah Valantine sells $279,728 in stock - Investing.com UK
New Analysis from CareDx (CDNA) Highlights Allograft Outcomes - GuruFocus
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
Caredx Insider Sold Shares Worth $279,728, According to a Recent SEC Filing - marketscreener.com
CareDx (CDNA) director logs RSU grant and pre-planned share sale - Stock Titan
CareDx (CDNA) director receives 9,795-share RSU grant, holdings reach 58,943 - Stock Titan
CareDx (NASDAQ: CDNA) grants 9,795 RSUs to board member Riggsbee - Stock Titan
CareDx (CDNA) director Fred E. Cohen receives 9,795-share RSU grant - Stock Titan
CareDx (CDNA) director receives 9,795 RSUs in equity grant - Stock Titan
Director George Bickerstaff receives 9,795 RSUs at CareDx (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) director awarded 9,795 restricted stock units - Stock Titan
CareDx Shareholders Back Directors, Auditor and Equity Plan - The Globe and Mail
CareDx study links kidney test elevations to graft loss risk By Investing.com - Investing.com Nigeria
CareDx study links kidney test elevations to graft loss risk - Investing.com UK
CareDx sharpens precision diagnostics push with Naveris deal, AlloHeme plans - MSN
CareDx, Inc. Approves Amendment to 2024 Equity Incentive Plan and Reports 2026 Annual Meeting Results - Minichart
CareDx president and CEO John Hanna sells $528,442 in company stock - Investing.com India
CareDx president and CEO John Hanna sells $528,442 in company stock By Investing.com - Investing.com South Africa
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):